IM Cannabis (IMCC) Net Cash Flow Growth (5y) (2025 - 2026)

IM Cannabis (IMCC) Net Cash Flow Growth (5y) (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 89.86 Bn 88.00 Bn -
2 Teva Pharmaceutical Industries 35.84 Bn 32.10 Bn 1.97 Bn
3 Zoetis 32.70 Bn 30.76 Bn 1.62 Bn
4 Takeda Pharmaceutical 27.73 Bn 23.67 Bn 4.39 Bn
5 United Therapeutics 23.16 Bn 21.01 Bn 648.10 Mn
6 RedHill Biopharma 21.80 Bn 21.80 Bn -
7 Viatris 20.18 Bn 18.37 Bn 1.16 Bn
8 Neurocrine Biosciences 17.82 Bn 16.50 Bn 800.70 Mn
9 Elanco Animal Health 12.64 Bn 12.21 Bn 785.00 Mn
10 IM Cannabis 505,369.60 -226,752.91 1.03 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 15.20%
Dec 31, 2025 15.58%
Sep 30, 2025 58.92%
Jun 30, 2025 30.00%
Mar 31, 2025 26.37%